Tag: FDA

June 22, 2018

Cannabis Weekly Round-Up: Canada Legalizes Cannabis, Sales Start in October

The Investing News Network rounds up some of the biggest company and market news in the cannabis market for the...
June 20, 2018

Neovasc Reducer Implanted in First US Patient, Spikes Share Price

The Neovasc Reducer received its CE mark in the European Union in 2011. The company aims to have the device...
June 20, 2018

Cannabis Companies: Stocks on the TSXV

INN offers investors a growing list of all cannabis companies listed on the TSXV.
June 15, 2018

Cannabis Weekly Round-Up: The Amendment Fight for Bill C-45

The Investing News Network rounds up some of the biggest company and market news in the cannabis market for the...
June 13, 2018

FDA Grants Priority Review to Merck’s Supplemental Biologics License Application (sBLA) for GARDASIL 9

Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced that the U.S. Food and Drug Administration...
June 12, 2018

Cannabis Investment: Canadian Cannabis Stocks

The Canadian cannabis space is one of the hottest growing sectors. Are you interested in cannabis investment? Here's a look...
June 10, 2018

5 Top Weekly NASDAQ Biotech Stocks: Caladrius Soars 77 Percent

Caladrius Biosciences, Bellerophon Therapeutics, Celsion, Albireo Pharma and Trillium Therapeutics were last week's top gainers on the NASDAQ Biotechnology Index.
June 10, 2018

5 Top Weekly NASDAQ Biotech Stocks: MEI Pharma on Top

MEI Pharma, Anavex Life Sciences, Trillium Therapeutics, Celldex Therapeutics and Ophthotech were last week's top gainers on the NASDAQ Biotechnology...
June 8, 2018

Ironwood Pharmaceuticals Announces FDA Orphan Drug Designation for Olinciguat for the Treatment of Sickle Cell Disease

Ironwood Pharmaceuticals (NASDAQ: IRWD), a commercial biotech company, today announced that the U.S. Food and Drug Administration (FDA) has granted Orphan...
June 7, 2018

MannKind Successfully Completes Phase 1 Trial of Treprostinil Technosphere

MannKind (Nasdaq:MNKD) announced that it has completed a Phase 1 clinical study of Treprostinil Technosphere (TreT) under an Investigational New...